1. Home
  2. SVII vs AMRN Comparison

SVII vs AMRN Comparison

Compare SVII & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVII
  • AMRN
  • Stock Information
  • Founded
  • SVII 2021
  • AMRN 1989
  • Country
  • SVII United States
  • AMRN Ireland
  • Employees
  • SVII N/A
  • AMRN N/A
  • Industry
  • SVII Blank Checks
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVII Finance
  • AMRN Health Care
  • Exchange
  • SVII Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • SVII 116.6M
  • AMRN 216.0M
  • IPO Year
  • SVII 2022
  • AMRN 1993
  • Fundamental
  • Price
  • SVII N/A
  • AMRN $16.40
  • Analyst Decision
  • SVII
  • AMRN Strong Sell
  • Analyst Count
  • SVII 0
  • AMRN 1
  • Target Price
  • SVII N/A
  • AMRN $12.00
  • AVG Volume (30 Days)
  • SVII 4.8K
  • AMRN 189.4K
  • Earning Date
  • SVII 01-01-0001
  • AMRN 07-30-2025
  • Dividend Yield
  • SVII N/A
  • AMRN N/A
  • EPS Growth
  • SVII N/A
  • AMRN N/A
  • EPS
  • SVII 0.25
  • AMRN N/A
  • Revenue
  • SVII N/A
  • AMRN $214,112,000.00
  • Revenue This Year
  • SVII N/A
  • AMRN N/A
  • Revenue Next Year
  • SVII N/A
  • AMRN $7.88
  • P/E Ratio
  • SVII $47.30
  • AMRN N/A
  • Revenue Growth
  • SVII N/A
  • AMRN N/A
  • 52 Week Low
  • SVII $11.06
  • AMRN $7.08
  • 52 Week High
  • SVII $11.90
  • AMRN $17.18
  • Technical
  • Relative Strength Index (RSI)
  • SVII 52.57
  • AMRN 72.83
  • Support Level
  • SVII $11.64
  • AMRN $15.78
  • Resistance Level
  • SVII $11.78
  • AMRN $17.18
  • Average True Range (ATR)
  • SVII 0.09
  • AMRN 0.96
  • MACD
  • SVII 0.00
  • AMRN 0.21
  • Stochastic Oscillator
  • SVII 76.67
  • AMRN 86.99

About SVII Spring Valley Acquisition Corp. II

Spring Valley Acquisition Corp II is a blank check company.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: